FDA Approves New Abuse-Deterrent Alternative for Severe Pain Management
The FDA has approved oxycodone hydrochloride (RoxyBond) for the management of severe pain when other treatments have proved inadequate.
Related Articles
ICYMI: Highlights From ACCC Fall 2024
Top content from the Association of Cancer Care Centers (ACCC) fall conference included topics on patient participation, new cancer care programs, prior authorization processing, and…
Surveys on Patient Safety Culture for New Users
.yellow { background-color: #FDB81E; color: #323A45; } .yellow:hover { background-color: #FFF1D2; color: #323A45; }
ASH 2024: Zanubrutinib Monotherapy, With Obinutuzimab Demonstrates Durable Efficacy and Safety in CLL/SLL
Constantine Tam, MD, discusses zanubrutinib’s efficacy in CLL/SLL, emphasizing its durability, high response rates, safety considerations, and evolving therapeutic potential in combination with other agents.
Overcoming challenges in the implementation of clinical practice guidelines in China
Clinical practice guidelines (CPGs) are ‘systematically developed statements to assist practitioner and patient decisions about appropriate healthcare for specific circumstances’.1 The implementation of guidelines can…
AJMC Celebrates 30th Anniversary
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
National Action Alliance for Patient and Workforce Safety Webinar
National Action Alliance for Patient and Workforce Safety Webinar announcement
How Peer Support Helps Heal the Culture of Medicine from Within
HEALTH CARE WORKFORCE INNOVATION THEME ISSUE: By intentionally integrating and leveraging basic and essential elements of peer support in day-to-day operations, health care professionals and…
Study Finds Nearly 75% of Adolescents Experience Depression, Anxiety
Female adolescents were at an increased risk of experiencing depression and anxiety symptoms compared with males.
Webinar Series: Strengthening Primary Care Research
This series of webinars focuses on how to strengthen AHRQ’s primary research. For recordings of the presentations and slides, reference the webinars.